Page 10 - Patrick Tan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(0) Alset International and Novum Alpha plan to jointly develop, establish and list a digital assets-based exchange-traded product on the SIX Swiss Exchange by Q4 2021 Novum Alpha is one of the industry's leading algorithmically managed digital asset management firms with a regional footprint in Singapore, Malaysia, Vietnam, Indonesia and Thailand The joint venture deepens Alset's position in the fast-growing global cryptocurrency market which recently topped US$2.0 trillion in value in April 2021 BETHESDA, MD / ACCESSWIRE / April 21, 2021 / Alset EHome International Inc. (NASDAQ:AEI) (the "C...

The Straits Times A*Star, NUS Medicine jointly recruit genomics expert Kevin White Dr Kevin White will take on the role of programme director of nucleic acid therapeutics and senior group leader at the Genome Institute of Singapore.PHOTOS: A*STAR, SCREENGRAB FROM GOOGLE MAPS PublishedApr 15, 2021, 6:24 pm SGT https://str.sg/Jyhh They can read the article in full after signing up for a free account. Share link: Or share via: Sign up or log in to read this article in full Sign up All done! This article is now fully available for you Read now Get unlimited access to all stories at $0.99/month fo...

Phase II of Singapore's National Precision Medicine strategy to begin in April 2021 Precision medicine is part of Singapore's Research, Innovation and Enterprise (RIE) 2025 strategic goal to transform and protect the health of every Singaporean. Identified as a priority by the Ministry of Health, precision medicine aims to understand how genomic, phenotypic, lifestyle and clinical factors contribute to the health of Singaporeans. It also supports the responsible use of health data in clinical applications with the longer-term goal of addressing Singapore's healthcare challenges in a sustainab...

Singapore launches next phase of National Precision Medicine Programme New national body established to further research insights, improve patient outcomes and create new economic opportunities for the biomedical technology industry. Precision Health Research, Singapore SINGAPORE, 7 April 2021 – Precision medicine is part of Singapore’s Research, Innovation and Enterprise (RIE) 2025 strategic goal to transform and protect the health of every Singaporean. Identified as a priority by the Ministry of Health, precision medicine aims to understand how genomic, phenotypic, lifestyle and clini...

Novel CRISPR-based gene editor developed to correct mutations that cause genetic disorders A team of researchers from the Agency for Science, Technology and Research's (A*STAR) Genome Institute of Singapore (GIS) have developed a CRISPR-based gene editor, C-to-G Base Editor (CGBE), to correct mutations that cause genetic disorders. Their research was published in Nature Communications on 2 March 2021. One in seventeen people in the world suffers from some type of genetic disorder. Chances are, you or someone you know - a relative, friend, or colleague - is one of approximately 450 million pe...